GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Harvard Bioscience HBIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

9.09

+8.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Harvard Bioscience

Our reporting

We have not reported on Harvard Bioscience yet.

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -0.65 a share.

Past results

Reported against what analysts expected

11 Aug 202612 May 202612 Mar 20266 Nov 202511 Aug 202512 Mar 2025
Earnings per share-0.14-0.33-0.64-0.28-0.100.60
Forecast-0.21-0.620.040.05-0.250.07
Revenue$22.7m$20.8m$23.7m$20.6m$20.4m$24.6m
Forecast$21.4m$21.2m$23.1m$20.0m$18.8m$24.1m

Key events

  1. 16 Mar 202610-to-1 reverse split
  2. 21 Oct 2013Listed

Harvard Bioscience in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.